"but I’d caution that Nearmap like any stock carries substantial risks around competition, valuation, and execution in particular." Hard to question competition and execution at this rate....
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game